Skip to main content
. 2016 Apr 25;5(7):1654–1669. doi: 10.1002/cam4.688

Figure 6.

Figure 6

Clinical outcomes of the patients with allo‐HSCT. (A) Survival analyses were performed in patients in terms of overall survival (i), cumulative incidence of relapse (ii), and cumulative incidence of NRM (iii). (B) Overall survival (i), cumulative incidence of relapse (ii), and cumulative incidence of NRM (iii) of the patients were analyzed grouped by MDSCs levels in the graft. (C) Overall survival (i), cumulative incidence of relapse (ii), and cumulative incidence of NRM (iii) of the patients were analyzed grouped by MDSCs levels in PBMCs after allo‐HSCT.